Crusekitug
Based on 1 Customer Validation
Crusekitug is a humanized monoclonal antibody targeting human interleukin 17A (IL-17A). Crusekitug specifically binds to IL-17A, blocking its signal transduction, thus exerting immunosuppressive and anti-inflammatory activities. Crusekitug is promising for research of autoimmune and inflammatory diseases, such as psoriasis and rheumatoid arthritis.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 97.949%
- CAS. Nr.: 2956768-50-4
- Molecular Weight:144.985 kDa
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Human IgG1 kappa
Human
|
IL-17A |
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG1-kappa
ELISA, FACS, Functional assay
-
Immobilized HY-P70527 IL-17A Protein, Human (HEK293, His) can bind Crusekitug. The EC50 for this effect is 43.03 ng/mL.
Chemical Information
-
CAS. Nr. 2956768-50-4
-
Appearance Liquid
-
Molecular Weight 144.985 kDa
-
Color Colorless to light yellow
-
SMILES
[Crusekitug]
-
Synonyms
QX-002N
-
Versand
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)